My patients don’t wait for me anymore. That’s not a complaint. It’s a clinical reality I had to sit with before I could do anything useful about it. Patients started arriving at appointments having already run their symptoms through an AI chatbot. Sometimes they’d decided not to come in at all. Sometimes they were right.
Read more…
AI chatbots and patient safety need physician design originally appeared in KevinMD.com.
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
